Galectin Therapeutics Inc. (GALT) Ownership

$4.33

north_east
$0.08 (1.88%)
Day's range
$4.21
Day's range
$4.45

Galectin Therapeutics Inc. Major Shareholders & Ownership History

Major Shareholder Name Reporting Date Shares Held Market Value Change in Shares Ownership
VANGUARD GROUP INC 11/07/2025 2.25 M $9.52 M   2.90% 3.54%
ADVISOR GROUP HOLDINGS, INC. 11/14/2025 1.22 M $5.24 M   -3.21% 1.93%
BLACKROCK, INC. 11/12/2025 797.67 K $3.38 M   -10.56% 1.26%
GEODE CAPITAL MANAGEMENT, LLC 11/12/2025 633.07 K $2.68 M   -4.97% 1.00%
MARSHALL WACE, LLP 11/13/2025 554.26 K $2.35 M   1,723.23% 0.87%
WEALTHSPIRE ADVISORS, LLC 11/14/2025 479.52 K $2.03 M   0.00% 0.76%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 446.58 K $1.89 M   131.15% 0.70%
LPL FINANCIAL LLC 11/12/2025 360.27 K $1.53 M   -1.83% 0.57%
GENEOS WEALTH MANAGEMENT INC. 10/22/2025 360.18 K $1.53 M   -14.90% 0.57%
COMMONWEALTH EQUITY SERVICES, LLC 10/22/2025 294.90 K $1.25 M   3.32% 0.46%
VIVALDI CAPITAL MANAGEMENT LP 11/17/2025 255.75 K $1.08 M   48.31% 0.40%
STATE STREET CORP 11/14/2025 230.34 K $975.49 K   14.63% 0.36%
MORGAN STANLEY 11/14/2025 228.34 K $967.00 K   9.45% 0.36%
RETIREMENT GUYS FORMULA LLC 10/21/2025 165.99 K $702.98 K   4.01% 0.26%
SOVRAN ADVISORS, LLC 10/31/2025 157.41 K $798.04 K   -16.70% 0.25%
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC. 11/12/2025 121.20 K $513.00 K   -0.09% 0.19%
NORTHERN TRUST CORP 11/14/2025 121.07 K $512.71 K   0.27% 0.19%
MILLENNIUM MANAGEMENT LLC 11/14/2025 110.42 K $467.64 K   -23.60% 0.17%
GROUP ONE TRADING, L.P. 11/12/2025 99.11 K $419.73 K   49.72% 0.16%
TRAYNOR CAPITAL MANAGEMENT, INC. 11/03/2025 99.10 K $419.69 K   1.02% 0.16%
HIGHTOWER ADVISORS, LLC 11/07/2025 88.38 K $374.27 K   12.21% 0.14%
GSA CAPITAL PARTNERS LLP 11/07/2025 87.09 K $369.00 K   100.00% 0.14%
CITADEL ADVISORS LLC 11/14/2025 72.30 K $306.19 K   4.63% 0.11%
CITADEL ADVISORS LLC 11/14/2025 71.31 K $301.98 K   -30.97% 0.11%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 69.00 K $292.56 K   42.27% 0.11%
TRUIST FINANCIAL CORP 11/03/2025 68.00 K $287.98 K   0.00% 0.11%
SIMPLEX TRADING, LLC 11/12/2025 67.34 K $285.00 K   50.67% 0.11%
QUBE RESEARCH & TECHNOLOGIES LTD 11/14/2025 60.87 K $257.77 K   290.92% 0.10%
HORIZON KINETICS ASSET MANAGEMENT LLC 11/14/2025 53.74 K $227.60 K   4.39% 0.08%
ANCORA ADVISORS, LLC 11/14/2025 52.38 K $221.83 K   302.92% 0.08%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 11/14/2025 52.10 K $220.90 K   -2.25% 0.08%
SYNOVUS FINANCIAL CORP 11/07/2025 48.00 K $203.28 K   0.00% 0.08%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 11/10/2025 44.99 K $190.53 K   100.00% 0.07%
VIRTU FINANCIAL LLC 11/14/2025 38.97 K $165.00 K   100.00% 0.06%
BLAIR WILLIAM & CO/IL 11/12/2025 37.88 K $160.44 K   0.00% 0.06%
LIDO ADVISORS, LLC 11/14/2025 36.33 K $153.85 K   100.00% 0.06%
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 10/29/2025 35.24 K $168.08 K   -0.80% 0.06%
UBS GROUP AG 11/13/2025 31.51 K $133.46 K   -81.23% 0.05%
STRATOS WEALTH PARTNERS, LTD. 11/06/2025 30.05 K $127.26 K   -50.54% 0.05%
MARINER, LLC 11/14/2025 27.57 K $116.76 K   0.23% 0.04%
SOLUTIONS 4 WEALTH, LTD 11/04/2025 25.38 K $107.47 K   -29.51% 0.04%
BANK OF AMERICA CORP /DE/ 11/14/2025 25.33 K $107.26 K   129.37% 0.04%
GLADSTONE INSTITUTIONAL ADVISORY LLC 10/22/2025 24.65 K $104.39 K   0.00% 0.04%
GOLDMAN SACHS GROUP INC 11/14/2025 22.01 K $93.23 K   -16.20% 0.03%
INSPIRE ADVISORS, LLC 10/29/2025 21.10 K $89.34 K   0.00% 0.03%
CAHABA WEALTH MANAGEMENT, INC. 10/17/2025 21.00 K $88.94 K   0.00% 0.03%
SUMMIT TRAIL ADVISORS, LLC 11/14/2025 20.00 K $84.70 K   0.00% 0.03%
WOLVERINE TRADING, LLC 11/14/2025 18.00 K $75.96 K   62.16% 0.03%
JEFFERIES FINANCIAL GROUP INC. 11/13/2025 17.30 K $73.27 K   100.00% 0.03%
TWO SIGMA INVESTMENTS, LP 11/14/2025 16.65 K $70.50 K   100.00% 0.03%

Galectin Therapeutics Inc. institutional Ownership - FAQ's

During the previous two years, 126 institutional investors and hedge funds held shares of Galectin Therapeutics Inc.. The most heavily invested institutionals were:

VANGUARD GROUP INC: 2.25 M

ADVISOR GROUP HOLDINGS, INC.: 1.22 M

BlackRock, Inc.: 797,669

GEODE CAPITAL MANAGEMENT, LLC: 633,067

MARSHALL WACE, LLP: 554,261

Wealthspire Advisors, LLC: 479,518

16.18% of Galectin Therapeutics Inc. stock is owned by institutional investors.

Institutional investors have bought a total of 13.48 M shares in the last 24 months. This purchase volume represents approximately $58.38 M in transactions.